Trial intelligence / Profile preview

PEG-asparaginase in Childhood ALL

NCT00192673Phase 4Unknown

Sponsor
Nordic Society for Pediatric Hematology and Oncology
Start
Jun 2005
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 4 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Nordic Society for Pediatric Hematology and Oncology. Status: unknown.

02

Drugs

pegaspargase
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on NCT00192673.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00192673.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call